These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6038356)

  • 1. Control of drugs.
    Br Med J; 1967 Sep; 3(5567):689-90. PubMed ID: 6038356
    [No Abstract]   [Full Text] [Related]  

  • 2. New drugs.
    Hunter AR
    Lancet; 1975 Sep; 2(7933):493-4. PubMed ID: 51296
    [No Abstract]   [Full Text] [Related]  

  • 3. New laws on control of drugs?
    Lancet; 1967 Sep; 2(7516):601-2. PubMed ID: 4166834
    [No Abstract]   [Full Text] [Related]  

  • 4. RULES, REGULATIONS AND RESEARCH.
    NEIBEL OJ
    New Physician; 1963 Dec; 12():A85-A87. PubMed ID: 14103668
    [No Abstract]   [Full Text] [Related]  

  • 5. The evolution of new drug legislation.
    Kelsey FO
    BMQ; 1966 Sep; 17(3):72-81. PubMed ID: 5978212
    [No Abstract]   [Full Text] [Related]  

  • 6. How does legislation protect the public from poisoning?
    Priest L
    Adv Sci; 1967 Feb; 23(116):511-7. PubMed ID: 6044857
    [No Abstract]   [Full Text] [Related]  

  • 7. New drugs and the Kefauver-Harris amendment.
    Krantz JC
    J New Drugs; 1966; 6(2):77-9. PubMed ID: 5917906
    [No Abstract]   [Full Text] [Related]  

  • 8. [INSPECTION OF DRUGS].
    SIDERIUS P
    Tijdschr Soc Geneeskd; 1964 Jan; 42():4-8. PubMed ID: 14137283
    [No Abstract]   [Full Text] [Related]  

  • 9. Limitations on the discovery and supply of medicines.
    Weatherall M
    Proc R Soc Med; 1974 Dec; 67(12 Pt 2):1287-92. PubMed ID: 4449879
    [No Abstract]   [Full Text] [Related]  

  • 10. New drugs: the AMA and the FDA.
    Appel JZ
    Ann Allergy; 1966 Jul; 24(7):333-6. PubMed ID: 5941864
    [No Abstract]   [Full Text] [Related]  

  • 11. [THE DRUG SUPPLY LAW].
    GOUDSMIT CJ
    Tijdschr Soc Geneeskd; 1964 Jan; 42():2-4. PubMed ID: 14137278
    [No Abstract]   [Full Text] [Related]  

  • 12. THE INVESTIGATIONAL DRUG BRANCH: A REVIEW OF OBJECTIVES AND FUNCTION.
    KELSEY FO
    J New Drugs; 1963; 3(4):250-5. PubMed ID: 14063363
    [No Abstract]   [Full Text] [Related]  

  • 13. REGULATIONS AFFECTING DRUG RESEARCH AND DEVELOPMENT: A HISTORICAL PERSPECTIVE.
    KLUMPP TG
    J New Drugs; 1963; 3(4):212-20. PubMed ID: 14063357
    [No Abstract]   [Full Text] [Related]  

  • 14. THE PHYSICIAN AS FINAL ARBITER?
    PAGE I
    Appl Ther; 1964 Apr; 6():293-5. PubMed ID: 14152073
    [No Abstract]   [Full Text] [Related]  

  • 15. United Kingdom Committee on safety of drugs.
    Pharmakotherapia; 1964; 2(1):207. PubMed ID: 5875714
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical investigation of new drugs.
    Pugsley LI
    Appl Ther; 1966 Mar; 8(3):243-9. PubMed ID: 5324973
    [No Abstract]   [Full Text] [Related]  

  • 17. [The new drug law of the German Democratic Republic and its significance in the appraisal of drugs].
    Richter J
    Pharm Prax; 1965; 5():115-24. PubMed ID: 5886701
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug control.
    Laurence DR
    Med Leg J; 1967; 35(2):56-70. PubMed ID: 6036592
    [No Abstract]   [Full Text] [Related]  

  • 19. [The new drug law of the German Democratic Republic and its significance for the evaluation of drugs].
    Richter J
    Z Arztl Fortbild (Jena); 1965 Apr; 59(8):413-20. PubMed ID: 5887305
    [No Abstract]   [Full Text] [Related]  

  • 20. AN INTERNATIONAL DRUG SAFEGUARD PLAN.
    FINNEY DJ
    J Chronic Dis; 1964 Jul; 17():565-81. PubMed ID: 14179659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.